Chemistry42
Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.
Find alternatives to Chemistry42
What it does
- Drug discovery
- Model training
- Data analysis
Features 7
- Generative ChemistryCreates novel small molecules with generative AI: de novo design, hit optimization, scaffold hopping, R-groups search.
- RetrosynthesisPredicts synthetic routes for uploaded or generated molecular structures.
- ADMET & Off-targetProfiles and optimizes absorption, distribution, metabolism and toxicity parameters plus selectivity.
- MDFlowEnd-to-end simulation workflows for biomolecules and complexes, from system build to reporting.
- AlchemistryEstimates relative binding free energy with physics-based methods to prioritize molecules.
- MolSpaceVisualizes generation results with Generative Topographic Mapping and compares them with public data.
- Model TrainingTrain predictive models on your own data to guide generation and annotate custom datasets.
Sources
- Pricing
-
Official documentation · 3 Sep 2026
Billing-period toggle visible on product page; access is request-gated rather than self-serve.
- Constraints
-
Official documentation · 2 Oct 2026
Derived from the security facts on this page, from the same source.
- Security
-
Official documentation · 2 Oct 2026
Company-wide Security & IT page covering client data and IP across engagements, applied to all listed products (page names none individually). ISO 27001 refers to the ISMS. Residency is client-chosen cloud servers, recorded as custom. Training, ZDR, DPA not stated.
- Sold within
-
Official documentation · 15 Sep 2026
pharma.ai/chemistry42 (already cited official-docs elsewhere on this record); offered standalone, no packaging restriction stated.
- Intended for
-
Trained on "the medicinal chemists' reaction toolbox"; positioned as a drug-discovery platform for hit identification/lead optimization used by medicinal/computational chemists.
Also from Insilico Medicine
-
Pharma.AI Platform
End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.
-
PandaOmics Platform
AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base; also answers literature-review questions through ChatPandaGPT.
-
PandaOmics Box Hardware
On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.
-
Biology42: Generative Biologics Platform
AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.
-
inClinico Application
Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.
-
Science42: DORA Application
AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.
-
MMAI Gym Platform
Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.
Open Insilico Medicine in the directory
Something wrong here? Send a correction — quote this product id: insilico-medicine-chemistry42.